Clinical Trial Update: Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Prader-Willi Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intranasal oxytocin vs placebo for hyperphagia in Prader-Willi syndrome has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperphagia
• Prader-willi Syndrome

Drugs mentioned

• intranasal oxytocin (oxytocin)

Snippet

Sponsor: Eric Hollander | Conditions: Prader-Willi Syndrome, Hyperphagia | Phase 2 | Status: COMPLETED | Results posted: 2025-02-07